Winner Medical Statistics

Total Valuation

Winner Medical has a market cap or net worth of CNY 23.35 billion. The enterprise value is 21.02 billion.

Market Cap	23.35B
Enterprise Value	21.02B

Important Dates

The next estimated earnings date is Thursday, April 24, 2025.

Earnings Date	Apr 24, 2025
Ex-Dividend Date	Sep 30, 2024

Share Statistics

Winner Medical has 582.33 million shares outstanding. The number of shares has decreased by -0.54% in one year.

Current Share Class	n/a
Shares Outstanding	582.33M
Shares Change (YoY)	-0.54%
Shares Change (QoQ)	-0.83%
Owned by Insiders (%)	69.86%
Owned by Institutions (%)	8.25%
Float	142.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	28.21
PS Ratio	2.86
PB Ratio	2.03
P/TBV Ratio	2.63
P/FCF Ratio	47.44
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.21, with an EV/FCF ratio of 42.71.

EV / Earnings	-20.73
EV / Sales	2.55
EV / EBITDA	21.21
EV / EBIT	49.56
EV / FCF	42.71

Financial Position

The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.22.

Current Ratio	1.92
Quick Ratio	1.45
Debt / Equity	0.22
Debt / EBITDA	2.69
Debt / FCF	5.41
Interest Coverage	8.05

Financial Efficiency

Return on equity (ROE) is -7.55% and return on invested capital (ROIC) is 1.74%.

Return on Equity (ROE)	-7.55%
Return on Assets (ROA)	1.44%
Return on Capital (ROIC)	1.74%
Revenue Per Employee	633,519
Profits Per Employee	-77,947
Employee Count	13,014
Asset Turnover	0.45
Inventory Turnover	2.63

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.99% in the last 52 weeks. The beta is 0.52, so Winner Medical's price volatility has been lower than the market average.

Beta (5Y)	0.52
52-Week Price Change	+6.99%
50-Day Moving Average	36.66
200-Day Moving Average	30.74
Relative Strength Index (RSI)	51.42
Average Volume (20 Days)	6,858,183

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Winner Medical had revenue of CNY 8.24 billion and -1.01 billion in losses. Loss per share was -1.73.

Revenue	8.24B
Gross Profit	3.70B
Operating Income	424.24M
Pretax Income	-1.12B
Net Income	-1.01B
EBITDA	766.70M
EBIT	424.24M
Loss Per Share	-1.73

Full Income Statement

Balance Sheet

The company has 5.71 billion in cash and 2.66 billion in debt, giving a net cash position of 3.05 billion or 5.23 per share.

Cash & Cash Equivalents	5.71B
Total Debt	2.66B
Net Cash	3.05B
Net Cash Per Share	5.23
Equity (Book Value)	12.08B
Book Value Per Share	19.71
Working Capital	4.56B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.33 billion and capital expenditures -836.33 million, giving a free cash flow of 492.28 million.

Operating Cash Flow	1.33B
Capital Expenditures	-836.33M
Free Cash Flow	492.28M
FCF Per Share	0.85

Full Cash Flow Statement

Margins

Gross margin is 44.86%, with operating and profit margins of 5.15% and -12.30%.

Gross Margin	44.86%
Operating Margin	5.15%
Pretax Margin	-13.62%
Profit Margin	-12.30%
EBITDA Margin	9.30%
EBIT Margin	5.15%
FCF Margin	5.97%

Dividends & Yields

This stock pays an annual dividend of 0.80, which amounts to a dividend yield of 2.00%.

Dividend Per Share	0.80
Dividend Yield	2.00%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.54%
Shareholder Yield	2.53%
Earnings Yield	-4.31%
FCF Yield	2.11%

Dividend Details

Stock Splits

The last stock split was on June 2, 2023. It was a forward split with a ratio of 1.4.

Last Split Date	Jun 2, 2023
Split Type	Forward
Split Ratio	1.4

Scores

Winner Medical has an Altman Z-Score of 3.38.

Altman Z-Score	3.38
Piotroski F-Score	n/a